Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 443 is a member of the Kruppel-type C2H2 zinc finger protein family, characterized by the presence of conserved C2H2 motifs that enable binding to DNA and subsequent regulation of gene transcription. It may play roles in transcriptional regulation and chromatin remodeling, although specific molecular mechanisms and drug interactions have not been elucidated. ZNF443 is encoded on human chromosome 19 (HGNC:20878, NCBI Gene: 10224, UniProt: Q9Y2A4), and its function is dependent on metal ion binding for structural integrity of its DNA-binding domain. No credible sources identify it as a validated therapeutic target, nor are drug interactions, actionable biomarker roles, or major safety concerns reported.
Not established for any drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 443 (ZNF443).